GT-00AxIL15 can promote NK cell proliferation; tumor immune infiltration; ADCC; and lytic capacity against the breast cancer cell lines ZR-75-1, MCF-7, and T-47D by targeting the tumor-associated MUC1 epitope 171. This evidence concerns the gene MUC1 and neoplasm.